期刊文献+

沉默GLUT-1表达对食管鳞癌细胞株TE-13增殖和迁移的影响 被引量:3

The effects of GLUT-1 knockdown on proliferation and migration of esophageal squamous cell carcinoma cell line TE-13
下载PDF
导出
摘要 目的研究沉默葡萄糖转运蛋白-1(glucose transporter protein-1,GLUT-1)的表达对食管鳞癌TE-13细胞增殖、周期及迁移的影响及可能的作用机制。方法采用慢病毒感染的方法将特异性针对GLUT-1基因的GLUT-1-sh RNA转入TE-13细胞,建立稳定干扰GLUT-1表达的TE-13细胞株,分成GLUT-1-sh RNA组和阴性对照组进行对比研究。采用实时荧光定量PCR和蛋白质印迹法检测GLUT-1-sh RNA对TE-13细胞GLUT-1 m RNA及其蛋白表达的影响。CCK-8法、FCM法和Transwell小室迁移实验分别检测沉默GLUT-1表达后对TE-13细胞增殖、细胞周期和迁移的影响;同时采用蛋白质印迹法检测细胞迁移以及乏氧相关蛋白的表达情况。结果采用慢病毒将GLUT-1-sh RNA转入TE-13细胞后,可明显下调GLUT-1蛋白(t=6.713,P<0.01)和m RNA的表达水平(t=4.181,P<0.05)。与阴性对照组相比,GLUT-1干扰后细胞的增殖至72 h(t=3.097,P<0.05)和96 h(t=3.497,P<0.05)明显被抑制,同时细胞的迁移能力可见下降,但是细胞周期至24 h未见影响;基质金属蛋白酶的MMP-9(t=6.895,P<0.01)和缺氧诱导因子HIF-1α(t=13.74,P<0.001)的表达明显下调,但是MMP-2的表达没有变化(t=2.582,P>0.05)。结论沉默GLUT-1的表达可抑制食管磷癌细胞株TE-13细胞的增殖和迁移,并明显下调细胞内MMP-9和HIF-1α蛋白的表达,为寻找靶向治疗食管癌新靶点提供了初步的实验基础。 Objective To investigate the effects of glucose transporter protein-1 (GLUT-l) knockdown on cell proliferation, cycle and migration of the esophageal squamous carcinoma cell line TE-13, and to study the background mechanism. Method Cell line TE- 13 were transfected with a lentiviral vector carrying the GLUT- 1-shRNA which is specific to GLUT-1 gene, then the stably interfered GLUT-1 expression cells were selected and all ceils were divided into 2 groups: GLUT-1-shRNA group and negative control group. Real-time PCR and western blot analysis were used to determine the mRNA and protein levels of GLUT-1 in negative control and GLUT-1-shRNA transfected TE-13 cells. The cell proliferation, cell cycle and migration were analyzed by CCK-8 assay, flow cytometry, transwell analysis, respectively. Furthermore, the levels of proteins that were involved in migration or hypoxia were analyzed by western blot. Result Lentivirus mediated shRNA knockdown of GLUT-1 significantly downregulated the mRNA level (t=-4.181, P〈0.05) and protein level (t=6.713, P〈0.01) of GLUT-1. Compared with negative control, the proliferation (72 h: t=-3.097, P〈0.05; 96 h: t=3.497, P〈0.05) of migration of TE-13 cells was significantly inhibited by GLUT-1 shRNA knockdown. However, the cell cycle showed no significant changes in 24 h after transfection. Moreover, the expression of MMP-9 (t=-6.895, P〈0.01) and HIF- 1α (t= 13.74, P〈0.001) were significantly downregulated by GLUT- 1 shRNA knockdown, while the expression of MMP-2 (t=-2.582, P〉0.05) remained unchanged before and after GLUT-1 knockdown. Conclusion GLUT-1 knockdown by shRNA significantly inhibits the proliferation and migration of TE-13 cells. And the levels of MMP-9 and HIF-1α are signifi- cantly downregulated by GLUT-1 knockdown, which provides preliminary theoretical basis in searching for targeted therapy for esophageal carcinoma.
出处 《癌症进展》 2016年第1期50-55,共6页 Oncology Progress
基金 上海市科学技术委员会基金(12ZR1418100)
关键词 食管鳞癌 GLUT-1 增殖 细胞周期 迁移 Esophageal squamous cell carcinoma GL UT-1 proliferation cell cycle migration
  • 相关文献

参考文献23

  • 1Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015[J]. CA Cancer J Clin, 2015, 65(1): 5-29.
  • 2Cui XB, Shen YY, Jin TT, et al. SLC39A6: a potential tar- get for diagnosis and therapy of esophageal carcinoma[J]. J Transl Med, 2015(13): 321.
  • 3Wang W, Liu L, Wang Z, et al. Impact of ABO blood group on the prognosis of patients undergoing surgery for esopha- geal cancer[J]. BMC Surg, 2015(15): 106.
  • 4Pan W, Sun Z, Xiang Y, et al. The correlation between high body mass index and survival in patients with esophageal cancer after curative esophagectomy: evidence from retro- spective studies[J]. Asia Pac J Clin Nutr, 2015, 24(3): 480- 488.
  • 5Xu WW, Li B, Lam AK, et al. Targeting VEGFR1- and VEGFR2-expressing non-tumor cells is essential for esoph- ageal cancer therapy[J]. Oncotarget, 2015, 6(3): 1790-1805.
  • 6Miles KA, Williams RE. Warburg revisited: imaging tumor blood flow and metabolism[J]. Cancer Imaging, 2008(8): 81-86.
  • 7Shim BY, Jung JH, Lee KM, et al. Glucose transporter 1 (GLUT1) of anaerobic glycolysis as predictive and prognos- tic values in neoadjuvant chemoradiotherapy and laparo- scopic surgery for locally advanced rectal cancer[J]. Int J Colorectal Dis, 2013, 28(3): 375-383.
  • 8Zhang C, Liu J, Liang Y, et al. Tumour-associated mutant p53 drives the Warburg effect[J]. Nat Commun, 2013(4): 2935.
  • 9Vasconcelos MG, Vasconcelos RG, Pereira de Oliveira DH, et al. Distribution of Hypoxia-lnducible Factor-1 ct and Glu- cose Transporter-1 in Human Tongue Cancers[J]. J Oral Maxillofac Surg, 2015, 73(9): 1753-1760.
  • 10Wood IS, Trayhum P. Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins[J]. Br J Nutr, 2003, 89(1): 3-9.

二级参考文献22

  • 1Bailey CJ, Turner RC. Metformin[J]. N Engl J Med, 1998, 334: 574-579.
  • 2Hadad SM, Appleyard V, Thompson AM. Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ER alpha negative MDA-MB-435 breast cancer model [ J ] . Breast Cancer Res Treat, 2009, 114(2): 391.
  • 3Zhou G, Myers R, Li Y, et al. Role of AMP-activated protein kinase in mechanism of melformin action [ J ] . J Clin Invest, 2001, 108: 1167-1174.
  • 4Li J, Jiang P, Robinson M, et al. AMPK-betal subunit is a p53-independent stress responsive protein that inhibits tumor cell growth upon forced expression [J].Carcinogenesis, 2003, 24: 827-834.
  • 5Hadad SM, Fleming S, Thompson AM. Targeting AMPK: A new therapeutic opportunity in breast cancer [ J ] . Crit Rev Oncol Hematol, 2008, 67(1): 1-7.
  • 6Ben Sahra I, Laurent K, Loubat A, et al. The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level [ J ] . Oncogene, 2008, 27(25): 3576-3586.
  • 7Buzzai M, Jones RG, Amaravadi RK, et al. Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth [ J ] . Cancer Res, 2007, 67(14): 6745-6752.
  • 8Gotlieb WH, Saurnet J, Beauchamp MC, et ah In vitro mefformin anti-neoplastic activity in epithelial ovarian cancer[J]. Gynecol Oncol, 2008, 110(2): 246-250.
  • 9Erik S. Mechanisms of cancer cell invasion [ J ] . Curt Opin Genet Dev, 2005, 15: 87-96.
  • 10Chambers AF, Matrisian LM. Charting view of the role of matrix metalloproteinases in metastasis [J].J Natl Cancer Inst, 1997, 89(7): 1260.

共引文献17

同被引文献13

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部